- Home
- CTNM vs FINS Comparison
CTNM vs FINS Comparison
Compare CTNM & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- FINS
- Stock Information
- Founded
- CTNM 2009
- FINS 2019
- Country
- CTNM United States
- FINS United States
- Employees
- CTNM N/A
- FINS N/A
- Industry
- CTNM
- FINS Finance/Investors Services
- Sector
- CTNM
- FINS Finance
- Exchange
- CTNM Nasdaq
- FINS Nasdaq
- Market Cap
- CTNM 378.7M
- FINS 323.3M
- IPO Year
- CTNM 2024
- FINS N/A
- Fundamental
- Price
- CTNM $14.14
- FINS $12.87
- Analyst Decision
- CTNM Strong Buy
- FINS
- Analyst Count
- CTNM 4
- FINS 0
- Target Price
- CTNM $29.25
- FINS N/A
- AVG Volume (30 Days)
- CTNM 82.5K
- FINS 78.0K
- Earning Date
- CTNM 11-06-2024
- FINS 01-01-0001
- Dividend Yield
- CTNM N/A
- FINS 9.97%
- EPS Growth
- CTNM N/A
- FINS N/A
- EPS
- CTNM N/A
- FINS N/A
- Revenue
- CTNM N/A
- FINS N/A
- Revenue This Year
- CTNM N/A
- FINS N/A
- Revenue Next Year
- CTNM N/A
- FINS N/A
- P/E Ratio
- CTNM N/A
- FINS N/A
- Revenue Growth
- CTNM N/A
- FINS N/A
- 52 Week Low
- CTNM $12.33
- FINS $11.61
- 52 Week High
- CTNM $22.00
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- FINS 49.61
- Support Level
- CTNM N/A
- FINS $12.79
- Resistance Level
- CTNM N/A
- FINS $13.11
- Average True Range (ATR)
- CTNM 0.00
- FINS 0.10
- MACD
- CTNM 0.00
- FINS 0.02
- Stochastic Oscillator
- CTNM 0.00
- FINS 36.84
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.